Brainstorm Cell Therapeutics (BCLI) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

BCLI Brainstorm Cell Therapeutics

Watchlist

1.240
-0.020-1.59%

Trading Nov 21 13:01 ET

7.07MMarket Cap-359P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Brainstorm Cell Q3 2024 GAAP EPS $(0.51) Beats $(0.57) Estimate
BenzingaNov 14 17:23 ET
Brainstorm Cell Therapeutics | 10-Q: Q3 2024 Earnings Report
SECNov 14 16:46 ET · Announcements
Brainstorm Cell Therptcs 3Q Loss $2.71M >BCLI
Dow JonesNov 14 16:41 ET
Brainstorm Cell Therptcs 3Q Loss/Shr 51c >BCLI
Dow JonesNov 14 16:41 ET
Express News | Brainstorm Cell Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update
ReutersNov 14 16:30 ET
Press Release: BrainStorm Cell Therapeutics Announces Third Quarter 2024 Financial Results and Provides Corporate Update
Dow JonesNov 14 16:30 ET

Comments

102914202

Nov 20 09:41

$Brainstorm Cell Therapeutics (BCLI.US)$ its doom everyone, its gonna be delisted

MARKET-TEST-DUMMY

Nov 19 07:04

Hmm

$Brainstorm Cell Therapeutics (BCLI.US)$

Trytosaveabit

Nov 11 05:04

Update

$Brainstorm Cell Therapeutics (BCLI.US)$ BrainStorm Cell Therapeutics and Pluri Partner to Support NurOwn Phase 3b Trial Manufacturing
PR Newswire· 3 mins ago
Memorandum of Understanding has been signed
NEW YORK, Nov. 11, 2024 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, today announced that it has entered into a Memorandum of Understanding (MOU) with Pluri Inc. (NASDAQ: PLUR) through its wholly o...